Targeted Genetics’ goal is to commercialize novel therapeutics, and both academic and corporate partnerships are key to accomplishing this goal. We partner with academic collaborators to access new technologies and with corporate collaborators to develop and commercialize product candidates. We continue to foster our current collaborative relationships as well as build additional collaborations to maximize our product opportunities.
Our capabilities enable us to form strategic partnerships with leading pharmaceutical and biotechnology companies, non-profit organizations and academic institutions, from early stage proof-of-concept studies to extensive development and commercial collaborations. Targeted Genetics has broad delivery capabilities and a development infrastructure that can be leveraged across multiple product opportunities in a range of therapeutic areas.
We have entered into various relationships with pharmaceutical and biotechnology companies, as well as non-profit organizations, to develop novel therapeutic product candidates. We are offering our partners:
-
Leading scientific expertise in gene delivery systems;
-
Expertise in quality assurance, quality control, research, preclinical development, regulatory affairs and clinical affairs;
-
Unmatched Adeno-Associated Viral manufacturing capabilities;
-
Experience with regulatory agencies - over 250 people have safely received AAV vectors made in our facility in a number of different clinical trials for a number of indications;
-
Broad intellectual property portfolio; and
-
Strong leadership and collaborative culture needed for mutually beneficial partnerships.
|
